Abstract
Background: Membrane-bound tumour necrosis factor (TNF) has a different binding affinity to two TNF receptors (TNFR1 and TNFR2) and shows different biological activities compared with TNF-α. We have developed a mutein, TNF-SAM2, which has modified TNF-α. It has higher tumour killing activity than TNF-α and fewer side effects. Materials and Methods: The difference between TNF-SAM2 and TNF-α was examined in view of the binding affinity to each TNF receptor, cytotoxicity and expression of genes using Colo205 cells. Results: The KD value of TNF-α (2.9×10-7 M) for TNFR1 was lower than TNF-SAM2 (6.9×10-7 M). Cytotoxicity of TNF-SAM2 was significantly higher than for TNF-α. RNA of Colo205 cells stimulated with TNF-SAM2 indicated that 80 genes increased by a factor of 2 or more, and 69 genes decreased. Conclusion: TNF-SAM2 can induce different intracellular signal transduction in Colo205 cells compared with TNF-α. TNF-SAM2 may have characteristics of the membrane-bound form despite the fact that is in a soluble form.
Footnotes
- Received May 23, 2006.
- Accepted June 20, 2006.
- Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved